3. Patient Presentation

4. Patient’s Changing ConditionMultiple Considerations To Balance

5. VALIANTHigh Early Risk of SCA

7. Implications of β-Blocker Underuse Prior To Device Implantation

9. DINAMIT Trial – 40-Day Wait

10. HAT - Home Use of Automated ExternalDefibrillators for Sudden Cardiac Arrest

11. Wearable Cardioverter Defibrillator

12. Adherence to WCD Use

13. WCDBridging the Waiting Period

14. Cleveland Clinic Post-PCI Registry WCD Use in Post-PCI Low EF Patients Associated With Improved Survival

15. Case

16. Patients With Low EF Following CABGSCA Risk During Recovery

17. Patients With Low EF Following CABGWCD Associated with Reduced Total Mortality

18. Case

19. MERIT-HFMechanism of Death in Heart Failure

20. Medical Therapy Optimization Required Prior to Managing Long-Term Arrhythmic Risk

21. Other Indications Where WCD Might Be of Use?

22. Care Team Model

23. Heart Rhythm SocietySudden Cardiac Death Primary Prevention Protocols

24. Abbreviations

25. Abbreviations (cont)

26. References

27. References (cont)

28. References (cont)

29. References (cont)